Neuropeptide FF receptor antagonist, RF9, attenuates the fever induced by central injection of LPS in mice

Peptides

Volumn 32, Issue 4, 2011, Pages 702-706

  Wang, Yi Qing ^a   Wang, Sheng Bin ^a   Ma, Jing Lin ^a   Guo, Jia ^a   Fang, Quan ^a   Sun, Tao ^a   Zhuang, Yan ^a   Wang, Rui ^a,b  

^a LANZHOU UNIVERSITY   (China)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Fever; Lipopolysaccharide (LPS); Mice; Neuroinflammation; Neuropeptide FF (NPFF); RF9

Indexed keywords

LIPOPOLYSACCHARIDE; NEUROPEPTIDE FF; RF 9; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; BRAIN VENTRICLE; CENTRAL NERVOUS SYSTEM; FEVER; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM TEMPERATURE;

ADAMANTANE; ANIMALS; DIPEPTIDES; FEVER; INJECTIONS, INTRAVENTRICULAR; LIPOPOLYSACCHARIDES; MALE; MICE; RECEPTORS, NEUROPEPTIDE;

ANIMALIA; MUS;

EID: 79952814267     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.12.001     Document Type: Article

References (47)

1. Allard M, Zajac J-M, Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, amorphinemodulating peptide, in rat central nervous system. Neuroscience 1992;49:101-16.
2. Belardelli F, Gessani S, Proietti E, Locardi C, Borghi P, Watanabe Y, et al. Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons. J Gen Virol 1987;68:2203-12.
3. Benamar K, McMenamin M, Geller EB, Chung YG, Pintar JE, Adler MW. Unresponsiveness of mu-opioid receptor knockout mice to lipopolysaccharide- induced fever. Br J Pharmacol 2005;144:1029-31. (Pubitemid 40593000)
4. Benamar K, Xin L, Geller EB, Adler MW. Blockade of lipopolysaccharide induced fever by a mu-opioid receptor-selective antagonist in rats. Eur J Pharmacol 2000;401:161-5. (Pubitemid 30488191)
5. Benamar K, Yondorf M, Barreto VT, Geller EB, Adler MW. Deletion of mu-opioid receptor in mice alters the development of acute neuroinflammation. J Pharmacol Exp Ther 2007;323:990-4. (Pubitemid 350146073)
6. Blatteis CM. The pyrogenic action of cytokines. In: Rothwell NJ, Dantzer RD, editors. Interleukin-1 in the brain. Oxford: Pergamon; 1992. p. 93-114.
7. Blatteis CM, Xin L, Quan N. Neuromodulation of fever: apparent involvement of opioid. Brain Res Bull 1991;26:219-23.
8. Bonini JA, Jones KA, Adham N, Forray C, Artymyshyn R, et al. Identification and characterization of two G protein-coupled receptors for Neuropeptide FF. J Biol Chem 2000;275:39324-31. (Pubitemid 32058954)
9. Carr DB, Bergland R, Hamilton A, Blume H, Kasting N, et al. Endotoxin-stimulated opioid secretion: two secretory pools and feedback control in vivo. Science 1982;217:8458.
10. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992;176:1387-98.
11. Davidson A, Milton AS, Rotondo D. A study of the pyrogenic actions of interleukin-1a and interleukin-1b: interaction with a steroidal and non-steroidal antiinflammatory agent. Br J Pharmacol 1990;100:542-6. (Pubitemid 20222289)
12. Dupouy V, Zajac J-M. Neuropeptide FF receptors in rat brain: a quantitative light microscopic autoradiographic study using [125I][D.Tyr1,(NMe) Phe3] NPFF. Synapse 1996;24:282-96. (Pubitemid 26386840)
13. Elshourbagy NA,AmesRS, Fitzgerald LR, Foley JJ, Chambers JK, et al. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J Biol Chem 2000;275:25965-71.
14. Fang Q, Wang YQ, He F, Guo J, Guo J, Chen Q, et al. Inhibition of Neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist. Regul Pept 2008;147:45-51.
15. Frances B, Lahlou H, Zajac JM. Cholera and pertussis toxins inhibit differently hypothermic and anti-opioid effects of Neuropeptide FF. Regul Pept 2001;98:13-8. (Pubitemid 32155487)
16. Hinuma S, Shintani Y, Fukusumi S, Iijima N, Matsumoto Y, et al. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat Cell Biol 2000;2:703-8.
17. Jhamandas JH, Simonin F, Bourguignon J-J, Harris KH, Neuropeptide. FF and neuropeptide VF inhibit GABAergic neurotransmission in parvocellular neurons of the rat hypothalamic paraventricular nucleus. Am J Physiol Regul Integr Comp Physiol 2007;292:R1872-80.
18. Lake JR,HammondMV,Shaddox RC, Hunsicker LM, Yang HY, Malin DH. IgG from Neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci Lett 1991;132:29-32.
19. Lake JR, Hebert KM, Payza K, Deshotel KD, Hausam DD, Witherspoon WE, et al. Analog of Neuropeptide FF attenuates morphine tolerance. Neurosci Lett 1992;146:203-6.
20. Lecron JC, Minault M, Allard M, Goube de Laforest P, Gombert J, Simonnet G. Modulation of human lymphocyte proliferation by FLFQPQRFamide, a FMRFamide-like peptide with anti-opiate properties. J Neuroimmnol 1992;38:1-8.
21. Leshin LS, Malven PV. Bacteremia-induced changes in pituitary hormone release and effect of naloxone. Am J Physiol Endocrinol Metab 1984;247:E585-91.
22. Liu Q, Guan XM, Martin WJ, McDonald TP, Clements MK, et al. Identification and characterization of novel mammalian Neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J Biol Chem 2001;276:36961-9.
23. Long NC, Otterness I, Kunkel S, Vander A-J, Kluger MJ. Roles of interleukin 1b and tumor necrosis factor in lipopolysaccharide fever in rats. Am J Physiol 1990;259:R724-8.
24. Malin DH, Lake JR, Arcangeli KR, Deshotel KD, Hausam DD, Witherspoon WE, et al. Subcutaneous injection of an analog of Neuropeptide FF precipitates morphine abstinence syndrome. Life Sci 1993;53:PL261-6.
25. Mansour A, Fox CA, Akil H, Watson SJ. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 1995;18:22-9.
26. Million M, Fioramonti J, Zajac JM, Buéno L. Effects of Neuropeptide FF on intestinal motility and temperature changes induced by endotoxin and platelet-activating factor. Eur J Pharmacol 1997;334:67-73. (Pubitemid 27417811)
27. Miñano FJ, Fernández-Alonso A, Benamar K, Myers RK, Sancibrián M, et al. Macrophage inflammatory protein-1beta (MIP-1beta) produced endogenously in brain during E. coli fever in rats. Eur J Neurosci 1996;8:424-8.
28. Mollereau C, RoumyM, Zajac JM. Opioid-modulating peptides: mechanisms of action. Curr Top Med Chem 2005;5:341-55. (Pubitemid 40614134)
29. Moulédous L, Barthas F, Zajac JM. Opposite control of body temperature by NPFF1 and NPFF2 receptors in mice. Neuropeptides 2010;44:453-6.
30. Myers RD, Lopez-Valpuesta FJ, Miñano FJ, Wooten M, Barwick VS, Wolpe SD. Fever and feeding in the rat: actions of intrahypothalamic interleukin-6 compared to macrophage inflammatory protein-1 beta (MIP-1 beta). J Neurosci Res 1994;39:31-7. (Pubitemid 24286532)
31. Panula P, Aarnisalo AA, Wasowicz K, Neuropeptide FF.Amammalian neuropeptide with multiple functions. Prog Neurobiol 1996;48:461-87.
32. Panula P, Kalso E, Nieminen M, Kontinen VK, Brandt A, Pertovaara A, et al. FF and modulation of pain. Brain Res 1999;848:191-6.
33. Perry SJ, Yi-Kung H-E, Cronk D, Bagust J, Sharma R, et al. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett 1997;409:426-30. (Pubitemid 27285899)
34. Quelven I, Roussin A, Zajac JM. Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists. Eur J Pharmacol 2005;508:107-14. (Pubitemid 40169908)
35. Quelven I, Roussin A, Burlet-Schiltz O, Gouarderes C, Tafani JA, Mazarguil H, et al. Dissociation of pharmacological pro and anti-opioid effects by Neuropeptide FF analogs. Eur J Pharmacol 2002;449:91-8.
36. 2+ channels in rat spinal ganglion neurones. Neuroreport 1996;7:2979-81.
37. Rosow CE, Miller JM, Pelikan EW, Cochin J. Opiates and thermoregulation in mice. I. Agonists. J Pharmacol Exp Ther 1980;213:273-83.
38. Roumy M, Garnier M, Zajac JM. Neuropeptide FF receptors 1 and 2 exert an anti-opioid activity in acutely dissociated rat dorsal raphe and periventricular hypothalamic neurones. Neurosci Lett 2003;348:159-62. (Pubitemid 36976830)
39. Roumy M, Zajac JM. Neuropeptide FF, pain and analgesia. Eur J Pharmacol 1998;345:1-11.
40. Saia RS, Carnio EC. Thermoregulatory role of inducible nitric oxide synthase in lipopolysaccharide-induced hypothermia. Life Sci 2006;79:1473-8.
41. Sherry B, CeramiA. Cachectin/tumor necrosis factor exerts endocrine, paracrine and autocrine control of inflammatory responses. J Cell Biol 1988;107:1269-77.
42. Simonin F, Schmitt M, Laulin JP, Laboureyras E, Jhamandas JH, MacTavish D, et al. RF9, a potent and selective Neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperanalgesia. Proc Natl Acad Sci USA 2006;103:466-71. (Pubitemid 43122424)
43. Ulugol A, Dost T, Dokmeci D, Akpolat M, Karadag CH, Dokmeci I. Involvement of NMDA receptors and nitric oxide in the thermoregulatory effect of morphine in mice. J Neural Transm 2000;107:515-21. (Pubitemid 30251735)
44. Vilim FS, Aarnisalo AA, Nieminen ML, Lintunen M, Karlstedt K, et al. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol Pharmacol 1999;55:804-11. (Pubitemid 29214599)
45. Wang YQ, Guo J, Wang SB, Fang Q, He F, Wang R. Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice. Peptides 2008;29:1183-90.
46. Yang HY, Fratta W, Majane EA, Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA 1985;2:7757-61. (Pubitemid 16204428)
47. Zajac JM, Latapie JP, Frances B. Opposing interplay between Neuropeptide FF and nitric oxide in antinociception and hypothermia. Peptides 2000;21:1209-13.